glp 1 anesthesia guidelines 2025 Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists ASA Advises No Longer Holding
Description
Mller TD, Finan B, Bloom SR, DAlessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ, Langhans W, Meier JJ, Nauck MA, Perez-Tilve D, Pocai A, Reimann F, Sandoval DA, Schwartz TW, Seeley RJ, Stemmer K, Tang-Christensen M, Woods SC, DiMarchi RD, Tschp MH
(2025) [14] conducted a randomized trial examining liraglutide withdrawal in patients with type 2 diabetes and reported a mean weight regain of 2.4 kg at 24 weeks post-discontinuation, corroborating the rebound trends identified in our subgroup analysis
Alginates (e.g., Gaviscon) which form a protective barrier on top of stomach contents
passing it off like theyre selling the brand-name item, but theyre not
The fasting trial showed 15% less rebound eating four hours after the last dose, confirming 4-6 hour duration
